Please use this identifier to cite or link to this item:
https://doi.org/10.1007/s00280-006-0270-1
| Title: | Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG) | Authors: | Yeo, W. Zee, B. Ma, B. Lam, K.C. Mo, F.K.F. Ng, E.K.W. Ho, R. Chan, A.T.C. Yeo, W. Boyer, M. Clarke, S. Beale, P. Chung, H.C. Roh, J.K. Rha, S.Y. Jeung, H.C. Ong, S.Y.K. Lim, R. Soo, R. Goh, B.C. |
Keywords: | First line chemotherapy Irofulven Stomach cancer |
Issue Date: | 2007 | Citation: | Yeo, W., Zee, B., Ma, B., Lam, K.C., Mo, F.K.F., Ng, E.K.W., Ho, R., Chan, A.T.C., Yeo, W., Boyer, M., Clarke, S., Beale, P., Chung, H.C., Roh, J.K., Rha, S.Y., Jeung, H.C., Ong, S.Y.K., Lim, R., Soo, R., Goh, B.C. (2007). Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer Chemotherapy and Pharmacology 59 (3) : 295-300. ScholarBank@NUS Repository. https://doi.org/10.1007/s00280-006-0270-1 | Source Title: | Cancer Chemotherapy and Pharmacology | URI: | http://scholarbank.nus.edu.sg/handle/10635/27257 | ISSN: | 03445704 | DOI: | 10.1007/s00280-006-0270-1 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
SCOPUSTM
Citations
14
checked on Feb 18, 2020
WEB OF SCIENCETM
Citations
13
checked on Feb 10, 2020
Page view(s)
151
checked on Feb 19, 2020
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.